🇮🇹 Italy Country × Condition
colorectal cancer Clinical Trials in Italy
Active clinical trials for colorectal cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇮🇹 Italy
Active Trials in Italy (5)
NCT06342440
Recruiting
Early Detection of Advanced Adenomas and Colorectal Cancer
Enrollment
2,000 pts
Country
🇮🇹 Italy
City of Hope Medical Center
View Trial → NCT06753903
Recruiting
Role of Photon Counting CT in Detecting Liver Metastatis From Colorectal Cancer
Enrollment
100 pts
Country
🇮🇹 Italy
IRCCS San Raffaele
View Trial → NCT05732623
Recruiting
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Enrollment
2,300 pts
Country
🇮🇹 Italy
San Raffaele University
View Trial → NCT05101382
Recruiting
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Enrollment
500 pts
Country
🇮🇹 Italy
IFOM ETS - The AIRC Institute of Mo...
View Trial → NCT07169734 Phase 1, Phase 2
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Enrollment
180 pts
Country
🇮🇹 Italy
Alentis Therapeutics AG
View Trial → Frequently Asked Questions
How many colorectal cancer clinical trials are active in Italy?
There are currently 5 active clinical trials for colorectal cancer with sites in Italy, of which 5 are actively recruiting patients.
How can I join a colorectal cancer clinical trial in Italy?
To join a colorectal cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are colorectal cancer trials in Italy?
Active colorectal cancer trials in Italy span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology